UNUSUAL STAGE-SPECIFIC EMBRYONIC ANTIGEN (TEC-4) DEFINED BY A MONOCLONAL-ANTIBODY TO EMBRYONAL CARCINOMA-CELLS DEFECTIVE IN THE EXPRESSION OF EMBRYOGLYCAN

被引:9
作者
DRABER, P
NOSEK, J
POKORNA, Z
机构
关键词
D O I
10.1073/pnas.86.23.9337
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:9337 / 9341
页数:5
相关论文
共 32 条
[1]   CELL-SURFACE ANTIGENS OF A CLONAL HUMAN EMBRYONAL CARCINOMA CELL-LINE - MORPHOLOGICAL AND ANTIGENIC DIFFERENTIATION IN CULTURE [J].
ANDREWS, PW ;
GOODFELLOW, PN ;
SHEVINSKY, LH ;
BRONSON, DL ;
KNOWLES, BB .
INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (05) :523-531
[2]  
ANDREWS PW, 1984, LAB INVEST, V50, P147
[3]   EMBRYONIC STEM-CELL LINES DERIVED FROM BLASTOCYSTS BY A SIMPLIFIED TECHNIQUE [J].
AXELROD, HR .
DEVELOPMENTAL BIOLOGY, 1984, 101 (01) :225-228
[4]   DIFFERENTIATION ANTIGENS OF MOUSE TERATOCARCINOMA STEM-CELLS DEFINED BY MONOCLONAL-ANTIBODIES [J].
DRABER, P ;
POKORNA, Z .
CELL DIFFERENTIATION, 1984, 15 (2-4) :109-113
[5]   THE EPITOPE OF MOUSE EMBRYONIC ANTIGEN(S) RECOGNIZED BY MONOCLONAL-ANTIBODY TEC-02 IS A CARBOHYDRATE CARRIED BY HIGH-MOLECULAR-WEIGHT GLYCOCONJUGATES [J].
DRABER, P .
CELL DIFFERENTIATION, 1987, 21 (02) :119-130
[6]  
DRABER P, 1980, J IMMUNOGENET, V7, P455
[7]  
DRABER P, 1985, EXP CLIN IMMUNOGENET, V2, P174
[8]   INHIBITION OF ADHESION OF F9 EMBRYONAL CARCINOMA-CELLS TO SUBSTRATUM BY A NOVEL MONOCLONAL-ANTIBODY, TEC-05, REACTIVE WITH A DEVELOPMENTALLY REGULATED CARBOHYDRATE EPITOPE [J].
DRABER, P ;
POKORNA, Z ;
NOSEK, J ;
HINZOVA, E .
DIFFERENTIATION, 1988, 37 (03) :205-214
[9]   MUTANTS OF EMBRYONAL CARCINOMA-CELLS DEFECTIVE IN THE EXPRESSION OF EMBRYOGLYCAN [J].
DRABER, P ;
MALY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5798-5802
[10]   EXPRESSION OF MOUSE EMBRYONIC EPITOPE TEC-2 ON HUMAN CARCINOMA-DERIVED CELL-LINES AND CHARACTERIZATION OF ITS GLYCOPROTEIN CARRIERS [J].
DRABER, P ;
BUBENIK, J ;
POKORNA, Z ;
JANDLOVA, T ;
TOULCOVA, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 968 (03) :291-299